The DOST pushed for Lagundi as a treatment for mild COVID-19 cases. The Department of Science and Technology (DOST) had pushed for Lagundi (Chinese chaste tree) as a treatment for mild COVID-19 cases. The Department of Science and Technology expressed optimism that Lagundi will soon be considered as a treatment to be used by patients … Read more
159 COVID-positive patients will participate in Phase 2 of lagundi clinical trials, according to DOST The Department of Science and Technology (DOST) had reported that 159 COVID-positive patients will participate in Phase 2 of lagundi (Chinese chaste tree) clinical trials. In a report on Manila Bulletin, DOST Secretary Fortunato “Boy” T. de la Peña on … Read more
Human clinical trials for lagundi as a COVID-19 supplement were expected to be completed soon. The human clinical trials on the use of lagundi or Chinese chaste tree as a COVID-19 supplement were expected to be completed soon. In a report on Manila Bulletin, the clinical trials on the use of lagundi as a COVID-19 … Read more
Results of trials on tawa-tawa and lagundi as COVID-19 treatment may be announced by end of February 2021, according to DOST. The Department of Science and Technology (DOST) on Friday said that the results of clinical studies on the use of tawa-tawa and lagundi as COVID-19 treatment may be announced by the end of February … Read more
The results of VCO clinical trials were expected to be released by the 2nd week of November, according to DOST. The Department of Science and Technology (DOST) on Saturday said that the results of the clinical trials on the efficacy of virgin coconut oil (VCO) against COVID-19 were expected to be released on the second … Read more